These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1321908)

  • 61. Selective chiral inhibitors of 5-lipoxygenase with anti-inflammatory activity.
    McMillan RM; Girodeau JM; Foster SJ
    Br J Pharmacol; 1990 Nov; 101(3):501-3. PubMed ID: 1963796
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
    Spaethe SM; Snyder DW; Pechous PA; Clarke T; VanAlstyne EL
    Biochem Pharmacol; 1992 Jan; 43(2):377-82. PubMed ID: 1310855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability.
    Delorme D; Ducharme Y; Brideau C; Chan CC; Chauret N; Desmarais S; Dubé D; Falgueyret JP; Fortin R; Guay J; Hamel P; Jones TR; Lépine C; Li C; McAuliffe M; McFarlane CS; Nicoll-Griffith DA; Riendeau D; Yergey JA; Girard Y
    J Med Chem; 1996 Sep; 39(20):3951-70. PubMed ID: 8831761
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The anti-inflammatory activities of an extract and compounds isolated from Platycladus orientalis (Linnaeus) Franco in vitro and ex vivo.
    Fan SY; Zeng HW; Pei YH; Li L; Ye J; Pan YX; Zhang JG; Yuan X; Zhang WD
    J Ethnopharmacol; 2012 Jun; 141(2):647-52. PubMed ID: 21619922
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.
    Teixeira MM; Hellewell PG
    Br J Pharmacol; 1994 Apr; 111(4):1205-11. PubMed ID: 8032607
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis.
    Kolasa T; Gunn DE; Bhatia P; Basha A; Craig RA; Stewart AO; Bouska JB; Harris RR; Hulkower KI; Malo PE; Bell RL; Carter GW; Brooks CD
    J Med Chem; 2000 Aug; 43(17):3322-34. PubMed ID: 10966751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
    Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
    Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-inflammatory action of orally active 5-lipoxygenase inhibitor TMK688.
    Yamamoto S; Jiang H; Kato R
    Pharmacology; 1994 May; 48(5):273-82. PubMed ID: 8016188
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of 5-lipoxygenase inhibitors on in situ LTB4 biosynthesis following calcium ionophore stimulation in the rat pleural cavity.
    Raychaudhuri A; Chertock H; Peppard J; White WD; Koeler J; DiPasquale G
    Agents Actions; 1993; 39 Spec No():C43-5. PubMed ID: 8273581
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4- benzodioxan as orally active 5-lipoxygenase inhibitors.
    Satoh Y; Powers C; Toledo LM; Kowalski TJ; Peters PA; Kimble EF
    J Med Chem; 1995 Jan; 38(1):68-75. PubMed ID: 7837242
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C.
    Hawthorne AB; Boughton-Smith NK; Whittle BJ; Hawkey CJ
    Gut; 1992 Apr; 33(4):513-7. PubMed ID: 1316305
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A23187 stimulates translocation of 5-lipoxygenase from cytosol to membrane in human alveolar macrophages.
    Pueringer RJ; Bahns CC; Monick MM; Hunninghake GW
    Am J Physiol; 1992 Apr; 262(4 Pt 1):L454-8. PubMed ID: 1314503
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo characterization of zymosan-induced mouse peritoneal inflammation.
    Rao TS; Currie JL; Shaffer AF; Isakson PC
    J Pharmacol Exp Ther; 1994 Jun; 269(3):917-25. PubMed ID: 8014878
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitor.
    Farina PR; Graham AG; Homon CA; Lazer ES; Hattox SE; Riska PS; Gundel RH; Wegner CD
    J Pharmacol Exp Ther; 1993 May; 265(2):483-9. PubMed ID: 8388452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.
    Satoh Y; Stanton JL; Hutchison AJ; Libby AH; Kowalski TJ; Lee WH; White DH; Kimble EF
    J Med Chem; 1993 Nov; 36(23):3580-94. PubMed ID: 8246226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of the cyclooxygenase-2 inhibitor NS-398 on thromboxane and leukotriene synthesis in rat peritoneal cells.
    Schuligoi R; Amann R; Prenn C; Peskar BA
    Inflamm Res; 1998 May; 47(5):227-30. PubMed ID: 9657255
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.
    Hogaboam CM; Donigi-Gale D; Shoupe TS; Bissonnette EY; Befus AD; Wallace JL
    Br J Pharmacol; 1992 Jan; 105(1):87-92. PubMed ID: 1596692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.